FY25 Vaccines for Children
Note: There have been new actions to this contract opportunity. To view the most recent action, please click here.
Looking for contract opportunity help?
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
General Information
- Contract Opportunity Type: Combined Synopsis/Solicitation (Updated)
- Updated Published Date: Jan 17, 2025 09:10 am EST
- Original Published Date: Jan 16, 2025 04:16 pm EST
- Updated Date Offers Due: Jan 30, 2025 01:00 pm EST
- Original Date Offers Due: Jan 30, 2025 01:00 pm EST
- Inactive Policy: 15 days after date offers due
- Updated Inactive Date: Feb 14, 2025
- Original Inactive Date: Feb 14, 2025
- Initiative:
- None
Classification
- Original Set Aside:
- Product Service Code: 6505 - DRUGS AND BIOLOGICALS
- NAICS Code:
- 325412 - Pharmaceutical Preparation Manufacturing
- Place of Performance: Atlanta , GA 30341USA
Description
The Centers for Disease Control and Prevention (CDC) awards contracts to the manufacturers of pediatric vaccines for the purchase of standard commercial pediatric vaccines. Vaccines are one of the most cost-effective ways to prevent disease and reduce healthcare costs. The Vaccine for Children (VFC) program, established pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA ’93), guarantees federal support for the purchase and supply of sufficient quantities of vaccine to the States to cover a defined group of children. The program helps assure the implementation of effective immunization practices and proper use of vaccines to achieve higher immunization coverage. Children (18 years-of-age or younger) who qualify for immunization through the VFC purchase program include those who are (1) Medicaid-eligible, (2) without health insurance, (3) American Indian/Alaska native (as defined in Subsection (h)(3) of the OBRA ’93), or (4) children with health insurance, which does not cover the cost of vaccines, if they receive their immunizations at a Federally-qualified health center or rural health clinic (as defined by the Social Security Act). Health care providers who agree to certain requirements are eligible through the States to receive free vaccine through this VFC purchase program. The establishment of these contracts provides an opportunity to utilize VFC funds and Section 317 vaccine purchase funds to obtain vaccines at prices below those available in the commercial marketplace. In addition, awardees may opt to purchase additional quantities of vaccine under any resulting contract to provide immunizations for children who are not federally vaccine-eligible children using state and local funds. Offerors for this requirement must be manufacturers of pediatric vaccines in accordance with 42
U.S.C. § 1396s. The term "manufacturer" means any corporation, organization, or institution, whether public or private (including Federal, State, and local departments, agencies, and instrumentalities), which manufactures, imports, processes, or distributes under its label any pediatric vaccine. The term "manufacture" means to manufacture, import, process, or distribute a vaccine.
Attachments/Links
Contact Information
Contracting Office Address
- 1600 CLIFTON ROAD
- ATLANTA , GA 30333
- USA
Primary Point of Contact
- James Sprigler
- zbs6@cdc.gov
- Phone Number 404.498.3879
Secondary Point of Contact
- David Dombeck
- vwj8@cdc.gov
- Phone Number 470.488.2695
History
- Feb 15, 2025 12:04 am ESTCombined Synopsis/Solicitation (Updated)
- Jan 17, 2025 09:10 am ESTCombined Synopsis/Solicitation (Updated)
- Jan 16, 2025 04:16 pm ESTCombined Synopsis/Solicitation (Original)